Adjunctive Treatment for Decreasing Symptoms of Schizophrenia
Public ClinicalTrials.gov record NCT00222235. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST)
Study identification
- NCT ID
- NCT00222235
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- University of Maryland, Baltimore
- Other
- Enrollment
- 240 participants
Conditions and interventions
Conditions
Interventions
- d-cycloserine Drug
- glycine Drug
- placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 54 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 1999
- Primary completion
- May 31, 2004
- Completion
- May 31, 2004
- Last update posted
- Aug 19, 2019
2000 – 2004
United States locations
- U.S. sites
- 4
- U.S. states
- 3
- U.S. cities
- 4
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCLA/VA Greater Los Angeles Health Care System | Los Angeles | California | 90073 | — |
| Maryland Psychiatric Research Center | Baltimore | Maryland | 21228 | — |
| Zucker Hillside Hospital | Glen Oaks | New York | 11004 | — |
| Nathan S Kline Institute for Psychiatric Research | Orangeburg | New York | 10982 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00222235, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 19, 2019 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00222235 live on ClinicalTrials.gov.